Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma
References
Additional references
Asbestos Diseases Research Institute. Technical report for Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. www.adri.org.au/research_guidelines_mpm.html (accessed 23 March 2013).
Agarwal P, Seely J, Matzinger F, MacRae R, Peterson R, Maziak D, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image‐guided biopsy versus surgical biopsy. Radiology 2006;241(2):589‐594.
Bayman N, Ardron D, Ashcroft L, Baldwin D, Booton R, Darlison L, et al. PIT: A phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention. BMJ Open 2016;6(1):e010589.
Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108(3):754‐8.
BTS. British Thoracic Society statement on malignant mesothelioma in the UK. Thorax 2007;62(Supplement 2):1‐19.
Bydder S, Phillips M, Joseph D, Cameron F, Spry N, De Melker Y, et al. A randomised trial of single‐dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. British Journal of Cancer 2004;91(1):9‐10.
Chapman E, Garcia Diéguez M. Radiotherapy for malignant pleural mesothelioma. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD003880.pub4]
Clive A, Standen S, Maskell N. Surgical and large bore pleural interventions in malignant pleural mesothelioma and radiotherapy trial (the SMART trial). Lung Cancer 2014;83:s81.
Cox J, Stetz J, Pajak T. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology, Biology, Physics 1995;31(5):1341.
Davies HE, Musk AW, Lee YC. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Current Opinion in Pulmonary Medicine 2008;14(4):326‐30.
De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch‐Belgian survey. Radiotherapy & Oncology 2003;68(3):299‐302.
Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organisation between 1994 and 2008. Bulletin of the World Health Organization 2011;89(10):716‐24.
Di Salvo M, Gambaro G, Pagella S, Manfredda I, Casadio C, Krengli M. Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma. Acta Oncologica 2008;47(6):1094‐8.
Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, et al. Malignant pleural mesothelioma. Journal of the National Comprehensive Cancer Network 2012;10(1):26‐41.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration, 2011.
Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Annals of Occupational Hygiene 2000;44(8):565‐601.
Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, et al. International Mesothelioma Interest Group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Archives of Pathology and Laboratory Medicine Online 2013 May;137(5):647‐67.
Häkkinen AM, Laasonen A, Linnainmaa K, Mattson K, Pyrhönen S. Radiosensitivity of mesothelioma cell lines. Acta Oncologica 1996;35(4):451‐6.
Lee C, Bayman N, Swindell R, Faivre‐Finn C. Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice.. Lung Cancer 2009;66(2):150‐6.
Metintas M, Ak G, Parspour S, Yildirim H, Erginel S, Alatas F, et al. Local recurrence of tumour at sites of intervention in malignant pleural mesothelioma. Lung Cancer 2008;61(2):255‐61.
O'Rourke N, Garcia JC, Paul J, Lawless C, McMenemin R, Hill J. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiotherapy Oncology 2007;84(1):18‐22.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Robinson B, Lake R. Advancements in malignant mesothelioma. New England Journal of Medicine 2005;335(15):1591‐603.
Robinson B. Malignant pleural mesothelioma: an epidemiological perspective. Annals of Cardiothoracic Surgery 2012;1(4):491‐6.
Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. European Respiratory Journal 2010;35(3):479‐95.
Stahel R, Weder W, Felip E. Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow‐up. Annals of Oncology 2009;20(Supplement 4):v73‐5.
Ung Y, Yu E, Falkson C, Haynes A, Stys‐Norman D, Evans W. The role of radiation therapy in malignant pleural mesothelioma: a systematic review. Radiotherapy Oncology 2006;80(1):13‐18.
Ung Yc, Yu E, Falkson C, Haynes AE, Stys‐Norman D, Evans W, the Lung Cancer Disease Site Group. The role of radiation therapy in malignant pleural mesothelioma. Program in Evidence‐based Care Practice Guideline Report No.: 7‐14‐3. Toronto (ON): Cancer Care Ontario, 2013.
